Clinicopathologic and Treatment Features of Long-Term Surviving Brain Metastasis Patients.

Archya DasguptaJayson CoJeff D WinterBarbara-Ann MillarNormand LaperriereDerek S TsangMonique van ProoijenAndrei DamyanovichRobert HeatonCatherine CoolensMark BernsteinPaul KongkhamGelareh ZadehAlejandro BerlinTatiana ConradFabio Y MoraesDavid B Shultz

Published in: Current oncology (Toronto, Ont.) (2021)

Most LTS were younger than 60 years old and had a single BM. Many received treatment with surgery or targeted, immune, or hormonal therapy.

Keyphrases

end stage renal disease
newly diagnosed
minimally invasive
stem cells
type diabetes
metabolic syndrome
adipose tissue
drug delivery
mesenchymal stem cells
multiple sclerosis
peritoneal dialysis
atrial fibrillation
insulin resistance
cerebral ischemia
smoking cessation